XML 43 R30.htm IDEA: XBRL DOCUMENT v3.20.4
Note 11 - Stockholders' Equity (Tables)
12 Months Ended
Dec. 31, 2020
Notes Tables  
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]
   
Number of
Shares
   
Weighted-
Average
Exercise Price
Per Share
   
Weighted-
Average
Remaining
Contract Term
 
Balance at January 1, 2019
   
1,726,522
    $
29.88
     
2.20
 
Warrants granted
   
444,445
    $
0.10
     
 
 
Warrants exercised
   
(435,264
)   $
0.35
     
 
 
Warrants expired/canceled
   
(19,637
)    
 
     
 
 
Outstanding at December 31, 2019
   
1,716,066
    $
25.23
     
1.57
 
Exercisable at December 31, 2019
   
1,646,214
    $
22.91
     
1.63
 
                         
Balance at January 1, 2020
   
1,716,066
    $
25.23
     
1.57
 
Warrants granted
   
--
    $
--
     
 
 
Warrants exercised
   
(599,582
)   $
2.81
     
 
 
Warrants expired/canceled
   
--
     
 
     
 
 
Outstanding at December 31, 2020
   
1,116,484
    $
37.27
     
0.49
 
Exercisable at December 31, 2020
   
1,046,631
    $
34.42
     
0.54
 
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]
   
Year Ended December 31,
 
   
2020
   
2019
 
Cost of revenues
  $
9,000
    $
3,000
 
Sales and marketing
   
176,000
     
185,000
 
Research and development
   
114,000
     
98,000
 
General and administrative
   
581,000
     
328,000
 
    $
880,000
    $
614,000
 
Share-based Payment Arrangement, Option, Activity [Table Text Block]
   
Number
of Shares
   
Weighted-
Average
Exercise
Price
   
Weighted-
Average
Remaining
Contractual
Life
   
Aggregate
Intrinsic
Value
 
Outstanding at January 1, 2020
   
291,807
    $
13.96
     
8.3
    $
280,000
 
                                 
                                 
Granted
   
615,500
    $
5.92
     
 
     
 
 
Forfeited/cancelled
   
(17,671
)   $
5.63
     
 
    $
1,840
 
Outstanding at December 31, 2020
   
889,636
    $
8.57
     
8.7
    $
--
 
Vested and Expected to Vest at December 31, 2020
   
598,092
    $
9.72
     
8.5
    $
--
 
Exercisable at December 31, 2020
   
230,836
    $
15.21
     
7.5
    $
--
 
Non Vested Stock Options Activity [Table Text Block]
   
Non-vested Stock
Options
   
Weighted-Average
Grant Date Fair Value
 
Outstanding at January 1, 2020
   
144,683
    $
6.38
 
Granted
   
615,500
    $
5.05
 
Vested
   
(88,683
)   $
5.72
 
Cancelled/forfeited
   
(12,700
)   $
4.82
 
Outstanding at December 31, 2020
   
658,800
    $
5.25
 
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
   
Year Ended December 31,
 
   
2020
   
2019
 
Expected life (years)
 
6
   
5
 
Expected volatility
 
116%
   
103%
 
Risk-free interest rate
 
0.54%
   
1.68%
 
Dividend yield
 
0%
   
0%